Drug intelligence / Profile preview

hydrocortisone acetate + bacitracin zinc + polymyxin B sulfate + neomycin sulfate

Development stage
Approved
Lead developer
Pfizer
Modality
Small Molecules, Peptides
Administration
Ophthalmic
01

Overview

**Hydrocortisone acetate + bacitracin zinc + polymyxin B sulfate + neomycin sulfate** is a fixed-dose ophthalmic corticosteroid and antibacterial ointment marketed as **Cortisporin Ophthalmic Ointment** and **Neo-Polycin HC Ophthalmic Ointment**. Hydrocortisone acetate suppresses ocular inflammation through glucocorticoid-receptor signaling, while neomycin, polymyxin B, and bacitracin provide complementary antibacterial activity through inhibition of bacterial protein synthesis, disruption of the Gram-negative outer membrane, and inhibition of bacterial cell-wall precursor recycling, respectively. It is used for steroid-responsive inflammatory conditions of the conjunctiva, cornea, and anterior ocular segment when bacterial infection is present or a substantial risk of bacterial infection exists, including selected infective conjunctivitides, chronic anterior uveitis, and inflammation associated with ocular burns or foreign-body injury.

Brand names
Cortisporin Ophthalmic OintmentNeo-Polycin HC Ophthalmic Ointment
Other names
bacitracin zinc + hydrocortisone acetate + neomycin sulfate + polymyxin B sulfateneomycin sulfate + polymyxin B sulfate + bacitracin zinc + hydrocortisone acetateneomycin and polymyxin B sulfates and bacitracin zinc with hydrocortisone acetate ophthalmic ointment
02

Targets

30S A-site (Bacterial ribosomal 30S A-site)GR (Glucocorticoid receptor)mitoribosome (Mammalian mitochondrial ribosome)C55-PP (Undecaprenyl pyrophosphate)

Beyond the preview

Go deeper on hydrocortisone acetate + bacitracin zinc + polymyxin B sulfate + neomycin sulfate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on hydrocortisone acetate + bacitracin zinc + polymyxin B sulfate + neomycin sulfate.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call